OVERVIEW

Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR Kit is organized by Asuragen, a Bio-Techne Brand.

Description:
Cystic fibrosis testing can be challenging for laboratories. Even though screening is recommended for all ethnicities, it can be difficult to provide reliable results for everyone, since most CFTR assays were designed based on outdated, ethnically-homogeneous data. Additionally, some assay workflows can be time-consuming, cost-prohibitive, or cumbersome for labs to use.

In this event, Asuragen is pleased to unveil the AmplideX^® PCR/CE CFTR Kit*, which is designed to provide the broadest coverage** of the U.S. population of any available targeted kit, with an easy-to-implement workflow. Recent large-scale diverse datasets informed assay design to bridge coverage gaps left by other targeted assays, while the application of AmplideX technology streamlines the testing process.

This event will include a 4 hour LIVE schedule starting at 11am EST/8am PST on January 20, 2022 along with one year of continually updated content from Jan 2022 - Jan 2023. All live content will be recorded and available for the full year.

Register now for access to:
• Live webinars with C.E. credits and Q&A sessions
• Presentations from knowledge experts in CFTR gene coverage variants
• Detailed AmplideX PCR/CE CFTR Kit information
• How to expand your lab menu with the AmplideX portfolio
• The opportunity to chat with an AmplideX expert

Note:
*For Research Use Only. Not for use in diagnostic procedures.
**Based on Beauchamp KA, et al. Genet Med. 2019.